Tumor cell lysates as immunogenic sources for cancer vaccine design-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor cell lysates as immunogenic sources for cancer vaccine design

Published:2014-11-02 Issue:11 Volume:10 Page:3261-3269
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

González Fermín E,Gleisner Alejandra,Falcón-Beas Felipe,Osorio Fabiola,López Mercedes N,Salazar-Onfray Flavio

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/21645515.2014.982996

Reference110 articles.

1. Therapeutic cancer vaccines: are we there yet?

2. Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

3. Adoptive cell transfer: a clinical path to effective cancer immunotherapy

4. Phase I Study of Adoptive T-Cell Therapy Using Antigen-Specific CD8+ T Cells for the Treatment of Patients With Metastatic Melanoma

5. Tumor Regression in Patients With Metastatic Synovial Cell Sarcoma and Melanoma Using Genetically Engineered Lymphocytes Reactive With NY-ESO-1

Cited by 126 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bacterial and cancerous cell membrane fused liposome coordinates with PD-L1 inhibitor for cancer immunotherapy;Nano Research;2024-08-03

2. Enhancing Dendritic Cell Cancer Vaccination: The Synergy of Immune Checkpoint Inhibitors in Combined Therapies;International Journal of Molecular Sciences;2024-07-09

3. Engineering nanomedicines for immunogenic eradication of cancer cells: Recent trends and synergistic approaches;Acta Pharmaceutica Sinica B;2024-06

4. Nanoparticle-Mediated Synergistic Chemoimmunotherapy for Cancer Treatment;International Journal of Nanomedicine;2024-05

5. Liposome Nanomedicine Based on Tumor Cell Lysate Mitigates the Progression of Lynch Syndrome-Associated Colon Cancer;ACS Biomaterials Science & Engineering;2024-04-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3